5.8 C
New York
Monday, November 16, 2026

Preventive health tech firm Cent raises $15 million

Must read

Trends News Stories Editorial
Trends News Stories Editorialhttps://trendsnewsstories.com/
Editorial desk at Trends News Stories (trendsnewsstories.com), an independent news site based in New Delhi, India. We publish original trending-news explainers across entertainment, sports, tech, business and health. Facts are checked against official sources and trusted outlets; we credit sources, note what is unconfirmed, and correct errors when we find them.

Preventive health tech company Cent has raised $15 million in a Series A funding round to expand its preventive health tech platform and grow its clinical and engineering teams. The round was led by Blume Ventures and existing investor South Park Commons, and it was announced on 27 October 2026.

Cent was founded in 2025 by Shashank ND, a co-founder of Practo, along with Anshul Khandelwal and Arpit Garg. The company describes itself as a preventive health intelligence company rather than a diagnostics lab or a wellness app. Its aim is to find disease risk in people who feel healthy and have no symptoms.

The preventive health tech funding will support research and development to expand AI-driven diagnostics and medical imaging, and the expansion of the company’s AI, engineering and clinical teams. The round combined equity and debt.

Preventive health tech funding for Cent began with a seed round of about $5 million in March 2026 from OneFlow Holdings and South Park Commons. The Series A lifts the amount raised by the company since its launch in 2025 to about $20 million.

Preventive health tech funding to expand screening

Cent’s main product is the Cent Check, a two-hour health assessment that combines full-body MRI, low-dose CT, DEXA scans for bone density and body composition, ECG, echocardiography and a panel of more than 100 blood biomarkers. The package is priced at Rs 27,500, which places it above a routine blood-test checkup and below a hospital admission for tests.

The company said it has completed 10,000 preventive whole-body scans across Bengaluru, Mumbai and Delhi since it began. It aims to scale that figure to 10 million scans by 2035, a target that would need new centres, more scanners and a much larger clinical workforce.

Preventive health tech companies in India drew steady funding through 2026. Cent was one of 13 digital health funding deals recorded in October, and preventive health and screening companies accounted for five of them, including Cent, Clinics on Cloud, Sunfox, Vytalyou and Aignosis. The funding tracker for the month put the combined value of the four dollar-denominated deals at $73.1 million.

What the Cent Check covers

The Cent Check looks for more than 300 conditions, including cardiac disease, cancer and neurological disorders, according to the company. The preventive health tech package is built around a health baseline for each person, so later changes can be spotted against that record. The two-hour visit is the core of the offer, and the company presents it as an alternative to checkups that rely mainly on blood tests and limited imaging. The Rs 27,500 price is for the full Cent Check visit, which packs the scans and blood tests into about two hours.

Cent said one in four people who walked in feeling healthy left with a finding that needed medical action. One in forty needed immediate medical attention. The company has not published a peer-reviewed breakdown of those findings, so the figures describe its own early results rather than an independent study.

The company also acquired Medsee, an AI platform that drafts structured radiology reports and flags findings for radiologist review. Medsee was founded by Chitra Singh. Cent said the acquisition will help it deliver faster and more consistent reporting as scan volumes rise.

Preventive health tech deals add up across India

The same MobiHealthNews brief that reported the Cent round also reported a second Indian deal. Clinics on Cloud, a maker of digital health kiosks, raised Rs 120 crore, about $13.5 million, in a Series A round led by Dubai-based Model42. The kiosks offer basic screening and consultations in places without a nearby clinic.

Cent plans to use the data from its scans to train models that spot disease risk earlier and to support clinical research. The company said the work depends on building a large set of baseline scans from people without symptoms, which is the reason it has set a target of 10 million scans by 2035.

More articles

Latest article